Akabane Virus

Overview, Taxonomy, and Genome Structure of Akabane Virus

Akabane virus (AKAV) is an arthropod-borne pathogen of significant veterinary importance, widely recognized for its role in causing congenital malformations and reproductive disorders in ruminants such as cattle, sheep, and goats [7, 11]. First identified in regions across Asia, Australia, and parts of the Middle East and Africa, AKAV has emerged as a key etiologic agent responsible for substantial economic losses in the livestock industry. The virus is primarily transmitted by biting midges (Culicoides spp.) and, in some instances, by mosquitoes, thereby linking its epidemiology directly to vector dynamics and climatic factors. Its presence has prompted extensive surveillance programs and has garnered the attention of international agencies such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO), which advocate for robust monitoring and control strategies due to the virus’s impact on animal health and international trade [7].

AKAV is characterized by its ability to infect multiple host species and by the sometimes subtle clinical manifestations in endemic regions where routine serological surveillance is critical for early detection and control. Field investigations have revealed high seroprevalence rates among domestic animals in various countries, underscoring the virus’s endemicity and the challenges it presents for herd immunity and vaccination strategies [1, 6]. Experimental and field studies using advanced techniques such as reverse genetics and reporter assays have further illuminated aspects of AKAV’s biology and cell tropism, enabling a more detailed understanding of its infection dynamics at the molecular level [2, 5].

Taxonomy

From a taxonomic perspective, Akabane virus belongs to the family Peribunyaviridae and is classified under the genus Orthobunyavirus. This classification places it within a group of segmented, negative-sense RNA viruses that share structural and genetic similarities with other arboviruses known to cause teratogenic effects in ruminants. The taxonomic delineation of AKAV is not only critical for diagnosis and vaccine development but also for understanding its evolutionary trajectory and reassortment potential. For example, instances of genomic reassortment have been documented, wherein the exchange of RNA segments between different AKAV genogroups has contributed to variations in pathogenicity and tissue tropism [9, 10].

Phylogenetic analyses based on the complete sequences of the three RNA segments, designated as S (small), M (medium), and L (large), have revealed the existence of multiple genogroups. These genogroups, including genogroup Ia and Ib, often display distinct epidemiological patterns and pathogenic characteristics. Studies in Asia have demonstrated that certain genogroups are more frequently associated with severe clinical outcomes, such as postnatal encephalomyelitis in calves or reproductive disorders during gestation [1, 4]. Consequently, the differentiation of AKAV strains into specific genogroups has substantial implications for disease surveillance, vaccine design, and the formulation of control measures, all of which are endorsed by authorities such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) in the broader context of managing economically critical animal pathogens.

Genome Structure

Central to understanding the biology and pathogenic mechanism of AKAV is a thorough appreciation of its genome structure. Akabane virus possesses a tripartite single-stranded, negative-sense RNA genome that is segmented into three distinct parts: the S, M, and L segments. Each segment plays a crucial role in the virus’s life cycle and contributes to its virulence.

S Segment

The S segment of AKAV is approximately 856 nucleotides in length and typically encodes two proteins: the nucleocapsid (N) protein, which is comprised of about 233 amino acids, and a nonstructural protein known as NSs, consisting of about 91 amino acids [1]. The nucleocapsid protein is essential for the encapsidation of viral RNA, forming a ribonucleoprotein (RNP) complex that protects the viral genome from degradation and is involved in the regulation of transcription and replication. The NSs protein, though smaller, has garnered attention for its role in modulating host immune responses and potentially influencing viral pathogenicity [2, 3]. Its relatively conserved nature across different strains further highlights its importance as a target for diagnostic assays, including ELISA and RT-PCR, which are critical for rapid detection and surveillance applications recommended by international agencies such as WOAH and FAO.

M Segment

The medium (M) segment is considerably larger, approximately 4,309 nucleotides in length, encoding a 1,401-amino-acid polyprotein that is subsequently cleaved into multiple functional proteins, including glycoproteins Gn and Gc as well as a nonstructural protein NSm. The glycoproteins Gn and Gc are embedded in the viral envelope and mediate receptor binding and membrane fusion, processes critical for viral entry into host cells [1, 8]. Notably, the Gc protein has been identified as a major target for neutralizing antibodies, with specific epitopes within this protein being highly conserved among diverse AKAV genogroups [4]. This antigenic conservation underpins ongoing efforts in vaccine development and serological detection, as highly conserved epitopes ensure broader cross-protection and enhanced diagnostic specificity. The cleavage of the polyprotein into mature glycoproteins is a finely tuned process, instrumental in determining the infectivity and tropism of the virus, and any alterations driven by reassortment or mutation events may directly affect pathogenic outcomes [2, 9].

L Segment

The large (L) segment, approximately 6,869 nucleotides long, encodes the RNA-dependent RNA polymerase (RdRp), a pivotal enzyme responsible for the replication and transcription of the viral genome. The RdRp, typically 2,511 amino acids in length, orchestrates the synthesis of viral mRNA from the negative-sense RNA template, thereby dictating the efficiency of viral replication within host cells [1]. The enzyme’s activity is central not only to the successful replication of AKAV but also to its ability to undergo genetic reassortment, a process whereby segments are exchanged between different virus strains, contributing to viral evolution and the emergence of new genotypes with altered pathogenic properties [9, 10]. Understanding the structure-function relationship of the RdRp has been instrumental in developing reverse genetics systems that facilitate the manipulation of the AKAV genome for vaccine research and the study of viral pathogenic mechanisms [2, 5].

Collectively, the tripartite genome structure of Akabane virus, with its segmented RNA architecture, affords a high degree of genetic plasticity. This structural organization allows for the possibility of genetic reassortment and mutation events, which can lead to shifts in virulence, host range, and antigenicity. Consequently, continuous genetic monitoring and detailed phylogenetic studies are imperative for anticipating potential outbreaks and for informing the strategic development of vaccines and therapeutics. Given the virus’s economic impact and the global movement of livestock, such genomic insights are pivotal for both national and international animal health agencies, including CDC, WHO, and WOAH.

By advancing our understanding of the intrinsic genomic architecture and taxonomic placement of AKAV, researchers are better positioned to develop precise diagnostic tools, craft effective vaccines, and implement enhanced surveillance protocols necessary for mitigating the risks posed by this economically critical pathogen.

Molecular Pathogenesis and Mechanisms of Viral Reassortment

Akabane virus (AKAV) exhibits a segmented, negative-sense RNA genome composed of three distinct segments, S, M, and L, which encode the nucleocapsid (N) protein and nonstructural proteins (e.g., NSs) in the S segment, the envelope glycoproteins and precursor polyproteins in the M segment, and the RNA-dependent RNA polymerase in the L segment. This segmented architecture inherently predisposes the virus to genetic reassortment, a process that plays a central role in its molecular pathogenesis by modulating virulence, transmission, and host tropism [1, 2].

Molecular Mechanisms Underlying Viral Pathogenesis

The nucleocapsid protein encoded on the S segment is highly conserved among diverse isolates of AKAV. Its primary function is to encapsulate and stabilize the viral genomic RNA and form the ribonucleoprotein (RNP) complex that is essential for replication and transcription [3]. Recent studies have underscored that even minor alterations in the N protein or its associated nonstructural proteins (such as NSs) can dramatically influence both the replication efficiency and cytopathogenic effects of the virus. For instance, reverse genetics experiments have demonstrated that deletion or amino acid substitutions within the NSs protein directly correlate with reduced viral replication kinetics in vitro, as well as diminished neurovirulence in in vivo models [2, 16]. The NSs protein has been suggested to function as a virulence factor by modulating host immune evasion and possibly interfering with interferon signaling pathways, thereby contributing to the virus’s capacity to establish a robust infection in key target tissues such as the central nervous system (CNS) [2, 17].

Furthermore, the envelope glycoproteins synthesized from the M segment serve as the main targets for neutralizing antibodies and play a pivotal role in mediating host cell entry. Structural studies have delineated the precise epitopes within the Gc protein, which when altered, can result in significant changes in antigenicity and neutralization profiles [4, 8]. Mutational changes in these glycoproteins, via either point mutations or segment reassortment, can therefore modulate the pathogenic potential of emerging strains. In vitro and in vivo investigations using reporter viruses have confirmed that the proper expression and conformational integrity of these glycoproteins are critical determinants of viral spread, tissue tropism, and ultimately, the severity of the disease in ruminants.

Mechanisms of Viral Reassortment

Reassortment is a major evolutionary mechanism for segmented viruses such as AKAV and involves the exchange of whole genome segments when two or more virus strains co-infect the same host cell. This process facilitates rapid genetic diversification, which can lead to the emergence of novel strains with altered pathogenic properties [2, 10]. The segmented nature of AKAV’s genome means that progeny viruses can possess a mosaic of segments derived from different parental strains. In particular, experimental studies have demonstrated that exchanging the S segment between different genogroups in a controlled reverse-genetics setting can modulate pathogenicity, with the NSs protein being a decisive factor for viral virulence [2].

Field isolates and phylogenetic analyses have provided further evidence of natural reassortment events among circulating AKAV strains. For example, the CX-01 isolate, which was isolated from goat blood in Yunnan, China, shows a distinct genomic constellation suggesting a recombination event wherein the L segment may have originated from a vaccine-derived strain while the S and M segments originated from field strains [12, 15]. Such genetic re-assortments are of significant epidemiological concern because they can introduce unexpected virulence factors into the virus population, potentially leading to outbreaks with atypical clinical presentations, ranging from congenital malformations to postnatal encephalomyelitis [13, 14].

The dynamics of reassortment are further compounded by the involvement of various arthropod vectors in the viral life cycle. Biting midges and mosquitoes, which serve as primary vectors for AKAV transmission, often cohabit environments where multiple viral strains circulate concurrently. This ecological scenario provides ample opportunities for co-infection and subsequent reassortment, thus facilitating the generation of novel viral genotypes with enhanced fitness, altered tissue tropism, or increased evasion from host immune responses [1, 10]. Surveillance studies and viromics-based diagnostic approaches have been instrumental in identifying these reassortant viruses in the field, underscoring the importance of integrating molecular epidemiology with vector surveillance as recommended by global organizations such as the CDC, WHO, and WOAH.

It is important to note that while reassortment can generate fitness advantages for the virus, certain genetic combinations may also lead to attenuation of pathogenicity. For instance, some reassortant viruses exhibit decreased replication rates in specific cell lines or display attenuated virulence in animal models, suggesting that successful reassortment events are subject to stringent biological constraints [2, 16]. These observations highlight the delicate balance between genetic diversity and viral fitness, which ultimately determines the pathogenic outcome in infected hosts.

Molecular investigations utilizing reverse genetics have been particularly insightful in dissecting the contribution of individual genome segments to the virulence phenotype. By constructing recombinant viruses bearing swapped segments between virulent and attenuated strains, researchers have been able to attribute specific pathogenic traits to distinct regions within the S, M, and L segments [2, 16]. This methodical approach not only elucidates the molecular determinants of AKAV virulence but also aids in identifying potential targets for vaccine development and antiviral therapy, efforts that are critically supported by global health agencies for economically significant livestock pathogens.

Thus, the interplay between AKAV’s segmented genome organization, the molecular functions of its structural and nonstructural proteins, and the dynamic process of reassortment forms the cornerstone of its pathogenesis and epidemiological behavior. An in-depth understanding of these mechanisms is essential for devising effective control strategies and mitigating the economic impacts associated with outbreaks of congenital and postnatal diseases in livestock worldwide.

Epidemiology of Akabane Virus

Akabane virus (AKAV) has emerged as a pathogen of significant economic importance in ruminant livestock across multiple continents, including Asia, Africa, Australia, and the Middle East [11, 20]. Its epidemiological profile is characterized by a widespread geographic distribution with periodic outbreaks that result in reproductive disorders such as abortions, stillbirths, and congenital malformations [7, 11]. The virus typically circulates in regions where intensive ruminant farming coincides with a climate that favors the activity of arthropod vectors. For example, in Yunnan Province, China, investigations have revealed substantial seroprevalence rates among cattle and goats, indicating active viral circulation and transmission via arthropod vectors such as biting midges [1, 18]. Moreover, serological surveys conducted in countries like Egypt and Nigeria further underscore the virus’s expansive reach in diverse ecological settings, where risk factors such as age, breed, sex, and local climatic conditions significantly affect infection rates [6, 19, 24].

The surveillance efforts documented in different regions provide critical insights into the impact of AKAV on livestock production. Investigators have repeatedly confirmed that seropositivity is higher in animals that are older or belong to specific high-risk breeds, and that certain geographic areas demonstrate a more pronounced burden of infection due to local environmental conditions [6, 19, 25]. This epidemiological heterogeneity reflects the interplay between virus endemicity, host susceptibility, and vector abundance. International organizations such as the Centers for Disease Control and Prevention (CDC) and the World Organisation for Animal Health (WOAH) have highlighted the importance of rigorous surveillance and prompt diagnostic protocols to mitigate the substantial economic losses attributable to such arboviruses.

Vector Dynamics in Transmission

Central to the epidemiology of AKAV is the role of arthropod vectors, particularly biting midges of the genus Culicoides. These tiny insects serve as the primary vehicles for viral dissemination, bridging geographical gaps and facilitating the rapid spread of infection among ruminant populations. Investigations in both field and laboratory settings have demonstrated that Culicoides species, including C. oxystoma, C. tainanus, and C. punctatus, possess high vector competence for supporting active viral replication and subsequent transmission [1, 21]. Detailed surveillance studies in Japan, for example, have shed light on the distribution and seasonal dynamics of these vectors, revealing that fluctuations in midge populations directly correlate with outbreaks of AKAV-related disease [21, 22].

Field investigations have further corroborated the role of biting midges in natural transmission cycles. In South China, isolations of AKAV from midges collected in cattle farms provided compelling evidence that these insects, beyond merely acting as mechanical carriers, are integral to the replication and maintenance of the virus within endemic foci [1]. Additionally, experiments involving oral inoculation of Japanese Culicoides species have confirmed that these vectors are not only susceptible to AKAV but also generate viral loads sufficient to initiate infection in susceptible hosts [22]. This capacity for viral amplification within vector tissues is critical, as it ensures that each midge can potentially seed new infections when blood-feeding on uninfected animals.

Beyond biting midges, some studies have noted the incidental detection of AKAV in mosquito species, suggesting that multiple arthropod groups could, under favorable ecological conditions, contribute to virus transmission [23]. However, the preponderance of data emphasizes the primacy of Culicoides in shaping the disease dynamics of AKAV. The high efficiency of these vectors is further supported by molecular and virological studies, which have documented that the virus undergoes genetic reassortment in the field, a process that may be facilitated by the mixed feeding habits and overlapping ecological niches of different vector species [10]. Such genetic exchanges can enhance the adaptive potential of the virus, potentially altering its virulence or host range, and underscore the need for continuous molecular epidemiological monitoring.

Climatic factors play a pivotal role in vector dynamics, with warmer temperatures and high humidity favoring the exponential growth of biting midge populations. In regions with a temperate climate, the seasonal abundance of vectors often coincides with peak periods of AKAV transmission. This temporal overlap between vector activity and the susceptible periods in gestating ruminants magnifies the risk of congenital infections [7, 11]. Consequently, strategic vaccination programs and vector control efforts are frequently timed to anticipate and preempt these seasonal peaks. Indeed, guidelines from international agencies such as the Food and Agriculture Organization (FAO) emphasize the importance of integrating vector surveillance data into disease control strategies, particularly for economically critical pathogens like AKAV.

The intrinsic biology of the vector further complicates efforts to control virus spread. The life cycle of Culicoides midges, with its dependence on microhabitats rich in organic material, creates localized hotspots of vector proliferation. These microhabitats can be found in proximity to livestock farms, where environmental management practices may inadvertently contribute to vector breeding. The use of light suction traps, as demonstrated in field studies in northern Honshu, Japan, has facilitated the detailed mapping of Culicoides species distribution, providing invaluable data for risk assessments and targeted control measures [21]. In parallel, laboratory-based investigations employing reverse genetics have begun to unravel the molecular interactions between AKAV and its arthropod hosts, elucidating how the virus exploits cellular pathways within the vector to establish infection and ensure efficient replication [5, 26].

Moreover, the dynamics of vector-host interactions are modulated by the density and movement of domestic animals. High-density farming operations typically create conditions that favor the rapid spread of AKAV, as numerous hosts provide ample opportunities for infected midges to feed and transmit the virus. This scenario has been documented in regions such as Egypt, where intense farming practices correlate with elevated seroprevalence rates [6, 19]. Likewise, the movement of livestock between farms can serve as a vehicle for both direct viral transmission and the concomitant spread of infected vectors, a factor that further underscores the need for coordinated regional surveillance programs.

In summary, the epidemiology and vector dynamics of Akabane virus transmission are intricately interwoven, with the widespread distribution of competent arthropod vectors fueling endemic and epidemic patterns among susceptible ruminant populations. The scientific literature consistently highlights the critical role of biting midges in maintaining and propagating AKAV, while pointing to the influence of ecological, climatic, and farming practices in modulating disease risk [1, 11, 21, 22]. The integration of vector surveillance with targeted animal health interventions, as recommended by global authorities such as CDC, WHO, and FAO, remains imperative for mitigating the impact of this economically significant arbovirus.

Diagnostics and Laboratory Characterization of Akabane Virus

The diagnostic landscape for Akabane virus (AKAV) has evolved considerably over recent years, driven by the need to accurately detect and characterize an agent that imposes significant economic losses in livestock industries worldwide. A comprehensive approach involving molecular, serological, and virological techniques is essential to unravel the complexities of this segmented negative-stranded RNA virus. Key laboratory methodologies, from virus isolation and in situ hybridization to advanced reverse genetics and reporter assays, have collectively deepened our understanding of AKAV’s biology and epidemiology, aligning with guidelines from the CDC and WOAH for monitoring economically critical pathogens.

Molecular and Serological Diagnostic Platforms

Central to AKAV diagnostics is the characterization of its tripartite genomic structure, composed of L, M, and S segments. The S segment, which encodes the nucleocapsid (N) protein, has proven particularly amenable to detection assays due to its high degree of conservation [1, 3]. Several studies have exploited this characteristic to develop serological assays that leverage monoclonal antibodies (mAbs) targeting epitopes within the N protein. For instance, a mAb designated as 2D3 was generated to specifically recognize a linear epitope between amino acids 168 and 182 of the N protein, facilitating the establishment of a double antibody sandwich ELISA with detection limits as sensitive as 6.25 ng/ml of purified antigen or 250 TCID₅₀/ml from cell culture supernatants [28]. Such assays play a pivotal role in seroepidemiological surveys and border control, as underscored by FAO recommendations in cases of economically significant animal diseases.

Parallel to ELISA development, the advent of molecular assays, including reverse transcription polymerase chain reaction (RT-PCR) and its derivatives, has transformed AKAV diagnostics. The targeting of conserved regions within the S segment allows for highly specific amplification and detection of viral RNA, a method validated in numerous outbreak investigations [1, 9]. More recently, the development of reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays has offered a rapid, sensitive, and field-deployable diagnostic alternative. This RT-LAMP method demonstrates a detection limit of 5.0 TCID₅₀/ml within an incubation period of approximately 60 minutes, and it has shown excellent concordance with semi-nested RT-PCR assays when applied to clinical samples from outbreak regions [31]. The speed and ease of RT-LAMP testing are particularly valuable in resource-limited settings, which aligns with the WHO’s emphasis on point-of-care diagnostics for zoonotic and economically critical pathogens.

In Situ Hybridization and Immunohistochemical Techniques

Advancements in in situ hybridization (ISH) techniques further extend the diagnostic arsenal for AKAV. An ISH method employing digoxigenin-labeled probes has been successfully applied to Vero E6 cells infected with AKAV, illuminating granular patterns of viral RNA in the cytoplasm [27]. This approach not only confirms the presence of AKAV in infected tissues but also provides spatial resolution that is critical for understanding viral tropism and the pathogenesis of congenital abnormalities in ruminants. Complementing ISH, immunohistochemical and immunofluorescence techniques have enabled detailed characterization of viral antigen distribution in infected tissues. For instance, studies evaluating congenital brain lesions in calves have identified AKAV antigens in central nervous system tissues using specific antibodies, thereby correlating histopathological findings with viral infection [30]. Such methods are indispensable for both diagnostic confirmation and research into the cellular mechanisms of viral-induced teratogenesis.

Reverse Genetics and Reporter Virus Systems

The establishment of reverse genetics systems has revolutionized the laboratory characterization of AKAV. By constructing full-length cDNA clones of the S, M, and L segments, researchers have successfully rescued recombinant viruses that mirror the cytopathic effects, plaque morphology, and growth kinetics of wild-type strains [2, 9]. This breakthrough not only facilitates the genetic manipulation of AKAV for pathogenesis studies, but it also provides a platform for vaccine research. A notable application of this approach involves the reassortment of viral gene segments to dissect the roles of individual components, such as the NSs protein encoded in the S segment, in viral replication and pathogenicity [2]. These reverse genetics models offer a controlled environment in which the interactions between viral factors and host cellular machinery can be meticulously studied, in accordance with the rigorous laboratory standards promoted by WOAH.

Reporter virus systems represent another leap forward in laboratory characterization. Recombinant AKAV strains expressing bioluminescent or fluorescent markers (e.g., nanoluciferase or mWasabi) have been developed to facilitate real-time monitoring of viral replication and cell tropism in vitro and in vivo [5]. These reporter viruses have been shown to maintain genetic stability over multiple passages while providing a sensitive readout that accelerates screening of antiviral compounds and vaccines. Furthermore, the incorporation of fluorescent protein reporters enables whole-organ imaging in animal models, elucidating the spatial dynamics of viral dissemination across different tissue types. Such innovative approaches are critical for tailoring targeted interventions and meet the high ethical and scientific standards advocated by international regulatory bodies.

Stable Cell Lines and Epitope Mapping

The generation of stable cell lines expressing the AKAV N protein, such as those created in BHK-21 cells, has provided robust tools for diagnostic assay development and functional analyses. These cell lines facilitate the production of consistent and high-quality antigen for immunoassays and have revealed insights into the inhibitory effects of ectopic N protein expression on viral replication, likely due to interference with viral mRNA transcription processes [29]. Concurrently, epitope mapping efforts have identified key neutralizing regions within the glycoprotein Gc. The identification of a conserved epitope between amino acids 1134 and 1142 using panels of neutralizing mAbs not only enriches our understanding of viral antigenicity but also informs the design of subunit vaccines and antigen-detection platforms [4]. This precise delineation of antigenic sites plays an essential role in refining diagnostic specificity and sensitivity, offering a direct translational benefit for both veterinary diagnostic laboratories and international surveillance programs.

By integrating these diverse diagnostic methodologies, ranging from serological assays and molecular techniques to advanced reverse genetic and reporter virus systems, laboratories have established a comprehensive framework for the detection and characterization of Akabane virus. This multifaceted approach not only adheres to the high standards mandated by the CDC, WHO, and WOAH for infection control and economic safeguarding, but also sets a precedent for ongoing research and rapid response in the face of emerging viral threats in livestock populations.

Host Serological Responses and Immunopathology in Akabane Virus Infections

Akabane virus (AKAV) infection in ruminants triggers robust serological responses that are reflective of the complex interplay between viral replication, host immune activation, and subsequent immunopathological outcomes. The seroconversion following AKAV exposure not only acts as a critical diagnostic marker but also elucidates the extent of host immune activation against this teratogenic, arthropod-borne pathogen. Serological studies conducted across different geographic regions and host species have shown that both neutralizing antibodies and specific immunoglobulins are induced, with titers and seroprevalence rates varying depending on the host species, age, breed, and environmental factors [1, 6, 19]. For example, cattle in endemic regions such as Yunnan Province have demonstrated significantly elevated neutralizing antibody titers compared to goats, suggesting a differential host response that may be related to innate variations in immune system activation between species [1, 6].

Serological Kinetics and Neutralizing Antibody Profiles

The onset and kinetics of the antibody response are of critical importance in the epidemiology and control of AKAV infections. Following viral infection, infected animals typically develop an initial immunoglobulin M response that evolves into a more robust immunoglobulin G response, which is responsible for neutralizing the virus and contributing to clearance. Several studies have established that high titers of neutralizing antibodies can persist for extended periods and correlate with decreased viral loads in tissues [1, 34]. The measurement of these neutralizing antibodies using competitive ELISA kits, virus neutralization tests, and more recently, reporter virus systems has provided insights into the adaptive immune response dynamics following natural infection as well as vaccination [1, 36]. For instance, differential neutralizing antibody titers have been reported in cattle with titers ranging from 1:32 to 1:128, while goats often display lower levels (e.g., 1:4 to 1:16) [1]. This disparity highlights a potential difference in both the magnitude and quality of the humoral immune response between these hosts.

Additionally, the use of monoclonal antibodies targeting key viral antigens such as the Gc glycoprotein and the Nucleocapsid (N) protein has refined our understanding of the fine antigenic determinants required for effective neutralization. Recent studies demonstrated that neutralizing epitopes located within highly conserved regions of the Gc protein elicit potent antibody responses capable of virus inactivation [4]. These epitopes not only serve as a basis for diagnostic assays but also help inform vaccine design strategies by focusing on the induction of a high-quality neutralizing antibody response in at-risk populations of livestock.

Immunopathological Manifestations in the Infected Host

Infection with AKAV is notorious for its immunopathological outcomes, typically manifesting in the central nervous system (CNS) of the fetus or neonate, leading to developmental anomalies such as hydranencephaly, arthrogryposis, and encephalomyelitis [7, 35]. Pathological examinations of infected animals consistently reveal multifocal lesions characterized by nonsuppurative encephalitis, perivascular lymphocytic infiltration, and neuronal degeneration, particularly in regions such as the midbrain, pons, and medulla oblongata [30, 35]. These changes reflect both direct viral cytopathic effects as well as immune-mediated damage resulting from the host’s inflammatory response. The activation of microglia and astrocytes, along with increased expression of markers such as glial fibrillary acidic protein (GFAP) in affected regions, underscores the role of innate immune responses in mediating CNS pathology [30].

The interplay of pro-inflammatory cytokines and chemokines further exacerbates immunopathology in AKAV infections. For example, in studies examining vaccine efficacy, the high levels of tumor necrosis factor-alpha (TNF-α) and other cytokines following vaccination with inactivated AKAV formulations suggested that an enhanced T-cell response may contribute to controlled viral replication and reduced tissue lesions [33]. These cytokine responses are crucial in mediating viral clearance but can also lead to collateral damage in sensitive tissues such as the brain in neonates where a robust immune response during critical periods of development is deleterious.

Experimental models, such as IFNAR1 knockout mice, have provided additional insights into the immunopathological mechanisms driving AKAV infection. In these models, infection with highly virulent strains leads to a uniform and rapid onset of lethal disease, accompanied by widespread viral replication and severe inflammatory changes in central and peripheral tissues [32]. The uniform lethality in these models underscores the importance of innate antiviral defense mechanisms and illustrates how the absence or attenuation of interferon signaling can result in unchecked viral proliferation and subsequent immunopathology.

Molecular Determinants and Immune Evasion

At the molecular level, AKAV employs multiple strategies to modulate host immune responses. The viral nonstructural proteins, particularly those encoded by the S segment, have been implicated in the modulation of host cell apoptosis and cytokine production, thereby influencing both viral replication kinetics and pathogenic outcomes [2, 16]. Mutagenesis studies have shown that deletion or alteration of certain nonstructural proteins, such as NSs and NSm, results in attenuated viral growth and diminished pathogenicity, emphasizing their role as virulence factors [2, 16]. The down-regulation of these viral determinants by mutagenesis leads to decreased viral replication in host tissues and a corresponding alteration in the pattern of serological responses. This suggests that the fine balance between viral immune evasion strategies and host immune activation largely determines the outcome of infection.

Implications for Disease Surveillance and Control

Given that AKAV poses significant economic challenges globally, impacting livestock industries in regions described by the World Organisation for Animal Health (WOAH) and relevant public health authorities like the CDC and FAO, the accurate monitoring of host serological responses becomes pivotal. Systematic serosurveillance using ELISA and virus neutralization tests not only provides an index of virus circulation within herds but also informs strategic vaccination programs designed to stimulate robust neutralizing antibody responses while mitigating immunopathological sequelae [1, 6, 19]. The integration of serological data into broader epidemiological frameworks has been essential in regions like China, Japan, and Egypt, where AKAV outbreaks have had severe reproductive impacts in livestock [1, 6, 19].

Moreover, the ability to correlate serological profiles with clinical presentations, such as congenital defects and postnatal encephalomyelitis, supports the notion that immunopathology serves as both a diagnostic marker and a therapeutic target. Public health agencies such as the CDC and FAO underscore the importance of these integrated surveillance approaches as part of comprehensive strategies to manage zoonotic and economically significant pathogens, further reinforcing the necessity for detailed immunological studies in Akabane virus infections.

Collectively, these findings highlight the intricate cascade initiated upon AKAV exposure, a cascade that not only defines serological profiles but also shapes the ensuing immunopathological environment that dictates both disease severity and long-term outcomes in infected hosts.

Reverse Genetics Systems and Insights into Viral Pathogenic Determinants

The advent of reverse genetics systems for Akabane virus (AKAV) has revolutionized our ability to dissect the molecular mechanisms underlying viral replication and pathogenicity. By constructing full-length cDNA clones for the three segmented viral genome, S, M, and L, researchers have been able to generate recombinant viruses with defined mutations, enabling precise manipulation of viral genes and the study of their individual contributions to pathogenesis and virus-host interactions [9]. This approach not only mirrors strategies used by international health authorities such as the WOAH and FAO for economically critical pathogens but also aligns with guidelines from the CDC and WHO regarding the rigorous study of zoonotic and arthropod-borne viruses.

One of the most illuminating applications of the reverse genetics system has been the evaluation of the S segment’s role in viral pathogenicity. In a key study, a T7 RNA polymerase-based system was employed to rescue recombinant AKAV viruses with targeted modifications in the S segment, such as the deletion of the nonstructural NSs gene and reassortment with segments from distinct viral genogroups [2]. The engineered rAKAV-7ΔNSs virus not only demonstrated markedly reduced viral replication in vitro, as evidenced by impaired growth in Vero cells, but also showed a corresponding attenuation in vivo with decreased mortality and lower RNA viral loads in experimental mouse models. Such observations underscore the pivotal role that the NSs protein plays in modulating virulence, functioning as a potential virulence factor that orchestrates early viral replication kinetics and engages host immune responses.

Further refinement in reverse genetics techniques has allowed the generation of reporter-expressing recombinant viruses that serve as high-resolution tools for dissecting virus replication dynamics and tissue tropism. For instance, the construction of recombinant viruses expressing nanoluciferase (Nluc) or mWasabi fluorescent proteins, when inserted into the S segment, yielded viruses that retained the replication kinetics and cytopathic properties of the parental wild-type strain [5]. These reporter viruses not only facilitate real-time monitoring of virus spread in cell culture but have also enabled in vivo tracking of viral dissemination, offering deep insights into the spatial and temporal aspects of viral infection within diverse host tissues. In this way, reverse genetics systems contribute to a more nuanced understanding of pathogenesis, especially regarding neuroinvasion and central nervous system involvement, phenomena that are consistent with postnatal encephalomyelitis observed in cattle and murine models [13].

By manipulating the genome and monitoring the phenotypic outcomes, researchers have also been able to assess the interplay between different viral segments. The comparative evaluation of a reassortant virus, rAKAV-7(S-K0505), demonstrated that while the S segment is crucial, the M and L segments further contribute to the overall pathogenic profile of AKAV [2]. The rAKAV-7(S-K0505) virus maintained similar growth kinetics in vitro but did not exhibit a significant reduction in mortality in suckling mice compared to its wild-type counterpart. This finding suggests a complex interplay between structural and nonstructural proteins that collectively dictate viral fitness and virulence. Such insights are critical, given that the segmented nature of AKAV not only facilitates reassortment but also poses continuous risks for the emergence of novel strains with altered pathogenic potentials, a concern closely monitored by international agencies concerned with animal health.

Additionally, reverse genetics has been indispensable in elucidating the functions of less well-characterized viral proteins. For example, the generation of NSm deletion mutants has revealed that even partial deletions in the NSm coding region can result in significant reductions in plaque size and replication efficiency, both in vitro and in vivo, highlighting its essential role in the virus life cycle and contributing to neuroinvasiveness [16]. These experiments demonstrate that each viral protein, whether structural or nonstructural, contributes distinctively to the pathobiology of AKAV, information that is paramount for the strategic development of effective vaccines and antiviral therapeutics.

From an epidemiological perspective, insights gained from reverse genetic studies inform our understanding of strain variability and the molecular determinants of host range. Detailed investigations into genotype-specific differences using engineered chimeric viruses reveal that mutations in critical regions can influence not only replication competency but also tissue tropism and the ability to breach the blood-brain barrier, which is a phenomenon observed in genogroup I strains showing enhanced neurovirulence [13]. This knowledge is particularly pertinent as it supports the formulation of refined risk assessments and vaccination strategies endorsed by well-regarded organizations like the CDC and WHO, thereby bolstering efforts to control outbreaks in economically important livestock populations.

In summary, the deployment of reverse genetics systems for AKAV has provided a robust platform for the dissection of viral replication and the identification of pathogenic determinants at the molecular level. By enabling the targeted alteration of genomic segments and the generation of reporter viruses, researchers can now map the contributions of individual proteins and domains to viral fitness and disease severity. This approach not only enhances our fundamental understanding of AKAV biology but also paves the way for the development of innovative control measures against this economically impactful pathogen.

Implications for Animal Health and Strategies for Disease Management

Akabane virus (AKAV) poses significant challenges to animal agriculture due to its capacity to cause a spectrum of reproductive disorders, from abortions and stillbirths to congenital malformations such as arthrogryposis and hydranencephaly, and, in certain cases, encephalomyelitis [7, 13]. Its impact on ruminants, particularly cattle, sheep, and goats, creates both direct economic losses through decreased herd productivity and indirect losses by necessitating costly surveillance and control measures. Detailed studies in Asia, Africa, and parts of Europe have revealed critical insights into the biological mechanisms underlying AKAV pathogenesis and transmission, further emphasizing an urgent need for integrated disease management strategies.

Biological Mechanisms and Epidemiological Considerations

The teratogenic effects of AKAV are closely linked to its ability to cross the placental barrier and interfere with proper fetal development. The virus’s replication in key fetal tissues, including the central nervous system, often results in irreversible neurological damage, as evidenced by lesions and histopathological changes in the brains and other organs of infected neonates [16, 35]. Research has shown that AKAV can be transmitted by various vectors such as Culicoides biting midges, which play a pivotal role in the dissemination of the virus across geographic regions [1, 21, 22]. Furthermore, the presence of specific viral proteins, such as the highly conserved nucleocapsid (N) protein and glycoprotein Gc, has been linked to viral replication and pathogenicity. The identification of neutralizing epitopes within the Gc protein, for example, offers a valuable insight into the antigenic makeup of the virus that may serve as a guide for vaccine design [4, 8].

The genetic diversity and evolution of AKAV, driven in part by reassortment events between different genogroups, are significant aspects of its epidemiology. Studies have documented instances where reassortment between distinct strains resulted in variations in pathogenicity, as noted in experiments that manipulated the S segment and other viral genes [2, 12]. These genetic changes can modify tissue tropism and virulence, for instance, differences in neurovirulence have been observed between genogroup I and II isolates in various animal models [13]. Such reassortment events complicate the control efforts because they may lead to the emergence of strains that overcome preexisting herd immunity. The use of reverse genetics systems, including reporter-expressing recombinant viruses, has been instrumental in dissecting the replication dynamics of AKAV, thereby improving our understanding of its pathogenesis and informing the development of targeted interventions [5, 9].

Diagnostic Innovations and Surveillance Challenges

Effective disease management of AKAV hinges on early and accurate diagnosis. Traditional serological methods, such as enzyme-linked immunosorbent assays (ELISAs) and virus neutralization tests, have been crucial in detecting antibodies in affected ruminant populations [6, 19]. Recent advancements include the development of rapid diagnostic assays such as RT-LAMP, which offer the sensitivity and speed required for on-site testing, thus allowing for prompt implementation of control measures in outbreak situations [31]. Enhancements in in situ hybridization and immunohistochemical techniques have further refined the ability to localize and characterize viral antigens within tissues, offering valuable insights into the progression of infection and associated tissue damage [27, 30]. In alignment with recommendations from global health authorities like the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO), these diagnostic improvements underscore the importance of robust surveillance systems in preventing widespread dissemination of AKAV.

Vaccination Strategies and Therapeutic Approaches

Vaccination represents the cornerstone of AKAV disease management, particularly in regions where the virus is endemic. Inactivated vaccines, which have been shown to induce high titers of neutralizing antibodies in vaccinated animals, offer a promising route for reducing viral spread and limiting reproductive losses [29, 34]. Detailed investigations into the optimal combination of inactivating agents (e.g., formaldehyde) and adjuvants (such as Imject® Alum) have demonstrated that such formulations can effectively stimulate both humoral and cellular immune responses, leading to the differentiation of CD4+ and CD8+ T-cells and the production of critical cytokines like TNF-α [33]. Additionally, experimental studies involving live models, for instance, using IFNAR1 knockout mice, have provided essential data regarding vaccine efficacy and viral pathogenicity in vivo, highlighting the potential for these animal models to serve as proxies for large ruminants in future vaccine trials [32, 37].

Moreover, emerging therapeutic strategies are not solely confined to prophylactic vaccination. Research focused on novel antivirals, such as Protoporphyrin IX (PPIX), has revealed potent virucidal activity through the direct inactivation of viral glycoproteins, thereby interrupting early stages of the infection process [34]. Similarly, strategies targeting specific molecular pathways, such as the inhibition of the c-Jun N-terminal kinase (JNK) cascade implicated in virus-induced apoptosis, may offer adjunct therapeutic avenues to reduce tissue damage and enhance clinical outcomes in infected animals [17].

Integrated Vector and Herd Management Considerations

Effective control of AKAV necessitates an integrated approach that considers both vector management and reinforcement of herd immunity. Given the significant role of biting midges and, in some regions, mosquitoes in facilitating viral spread, vector control measures, such as habitat modification, insecticide application, and physical barriers, are essential components of a holistic disease management program [1, 21]. In parallel, risk factor analyses have highlighted critical demographic variables, including age, breed, and management practices that influence seroprevalence rates. For example, higher antibody titers in older cattle or specific breeds indicate that herd composition and regional climatic conditions can substantially affect the epidemiology of AKAV [6, 19, 25]. Addressing these factors through targeted vaccination programs and improved herd management practices, supported by surveillance data from international organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), can lead to a more resilient agricultural sector capable of mitigating the detrimental effects of AKAV outbreaks.

In conclusion, the multifaceted implications of AKAV on animal health require a concerted effort that encompasses advanced diagnostic methods, efficient vaccination strategies, targeted antiviral therapies, and rigorous vector control. These approaches collectively form the backbone of an effective disease management strategy that, when implemented in coordination with global best practices endorsed by entities such as FAO and WOAH, holds the potential to substantially reduce the economic and biological impact of this pathogen on the livestock industry.

References

[1] Meng J, He Y, Li N, Yang Z, Fu S, Wang D, et al.. Akabane virus isolated from biting midges and its infection in local domestic animal, Yunnan, China: a field and laboratory investigation. Frontiers in Cellular and Infection Microbiology. 2025. DOI: https://doi.org/10.3389/fcimb.2024.1434045

[2] Na E, Jeong C, Chae S, Oem J. Investigating the reassortment potential and pathogenicity of the S segment in Akabane virus using a reverse genetics system. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-024-04459-0

[3] Wang R, Liang F, Lan X, Li G, Li F, Zhao M. Research progress on the N gene of Akabane virus. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1690905

[4] Wang J, Chen D, Wei F, Yu R, Xu S, Lin X, et al.. Identification of a broadly neutralizing epitope within Gc protein of Akabane virus using newly prepared neutralizing monoclonal antibodies.. Veterinary Microbiology. 2024. DOI: https://doi.org/10.1016/j.vetmic.2024.110123

[5] Liu J, Wang F, Zhao J, Qi Y, Chang J, Sun C, et al.. Bioluminescent and fluorescent reporter-expressing recombinant Akabane virus (AKAV): an excellent tool to dissect viral replication. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2024.1458771

[6] Metwally S, Bkear NM, Samir M, Hamada R, Elshafey BG, Batiha G, et al.. The First Serological Detection and Risk Factors Analysis of Akabane Virus in Egyptian Cattle. Animals. 2023. DOI: https://doi.org/10.3390/ani13111849

[7] Kirkland P. Akabane virus infection.. Revue scientifique et technique. 2022. DOI: https://doi.org/10.1079/cabicompendium.95163

[8] Ogawa Y, Eguchi M, Shimoji Y. Two Akabane virus glycoprotein Gc domains induce neutralizing antibodies in mice. Journal of Veterinary Medical Science. 2022. DOI: https://doi.org/10.1292/jvms.21-0670

[9] Chen D, Wang D, Wei F, Kong Y, Deng J, Lin X, et al.. Characterization and reverse genetic establishment of cattle derived Akabane virus in China. BMC Veterinary Research. 2021. DOI: https://doi.org/10.1186/s12917-021-03054-x

[10] Sun Y, Zhang R, Wang H, Sun Z, Yi L, Tu C, et al.. Viromics-based precision diagnosis of reproductive abnormalities in cows reveals a reassortant Akabane disease virus. BMC Veterinary Research. 2024. DOI: https://doi.org/10.1186/s12917-024-04400-5

[11] Beer M, Wernike K. Akabane Virus and Schmallenberg Virus (Peribunyaviridae). Encyclopedia of Virology. 2019. DOI: https://doi.org/10.1016/B978-0-12-809633-8.20939-4

[12] Gao H, Wang J, Yang Z, Xie J, He Y, Hong Q, et al.. Genetic and Pathogenic Characterisation of a Virulent Akabane Virus Isolated from Goats in Yunnan, China. Journal of Veterinary Research. 2022. DOI: https://doi.org/10.2478/jvetres-2022-0007

[13] Takenaka-Uema A, Matsugo H, Ohira K, Sekine W, Murakami S, Horimoto T. Different organ and tissue tropism between Akabane virus genogroups in a mouse model.. Virus Research. 2022. DOI: https://doi.org/10.1016/j.virusres.2022.198752

[14] Yanase T, Kato T, Hayama Y, Akiyama M, Itoh N, Horiuchi S, et al.. Transition of Akabane virus genogroups and its association with changes in the nature of disease in Japan.. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12778

[15] Tang H, Ren P, Qin S, Lin J, Bai A, Qin S, et al.. Isolation, genetic analysis of the first Akabane virus from goat in China. Journal of Veterinary Medical Science. 2019. DOI: https://doi.org/10.1292/jvms.18-0602

[16] Ishihara Y, Shioda C, Bangphoomi N, Sugiura K, Saeki K, Tsuda S, et al.. Akabane virus nonstructural protein NSm regulates viral growth and pathogenicity in a mouse model. Journal of Veterinary Medical Science. 2016. DOI: https://doi.org/10.1292/jvms.16-0140

[17] Mitomo S, Omatsu T, Tsuchiaka S, Nagai M, Furuya T, Mizutani T. Activation of c-Jun N-terminal kinase by Akabane virus is required for apoptosis. Research in Veterinary Science. 2016. DOI: https://doi.org/10.1016/j.rvsc.2016.06.007

[18] Wang J, Xin A, He Y, Xie J, Miao H, Li F, et al.. Genetic diversity and variation among Akabane virus field isolates from goats in Yunnan, China. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1545576

[19] Selim A, Marzok M, Gattan H, Hereba AM. A serological study and risk factors associated with Akabane virus infection in cattle in Egypt. Scientific Reports. 2025. DOI: https://doi.org/10.1038/s41598-025-02732-2

[20] . Akabane virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.95162

[21] Yanase T, Hayama Y, Shirafuji H, Tsutsui T, Terada Y. Surveillance of Culicoides biting midges in northern Honshu, Japan, during the period of Akabane virus spread. Journal of Veterinary Medical Science. 2019. DOI: https://doi.org/10.1292/jvms.19-0303

[22] Yanase T, Kato T, Hayama Y, Shirafuji H, Yamakawa M, Tanaka S. Oral Susceptibility of Japanese Culicoides (Diptera: Ceratopogonidae) Species to Akabane Virus. Journal of medical entomology. 2018. DOI: https://doi.org/10.1093/jme/tjy201

[23] Cao Y, Fu S, Song S, Cai L, Zhang H, Gao L, et al.. Isolation and Genome Phylogenetic Analysis of Arthropod-Borne Viruses, Including Akabane Virus, from Mosquitoes Collected in Hunan Province, China. Vector Borne and Zoonotic Diseases. 2019. DOI: https://doi.org/10.1089/vbz.2018.2267

[24] Oluwayelu D, Aiki-Raji C, Umeh E, Mustapha S, Adebiyi A. Serological Investigation of Akabane Virus Infection in Cattle and Sheep in Nigeria. Advances in Virology. 2016. DOI: https://doi.org/10.1155/2016/2936082

[25] Pourmahdi M, Karami S, Hajikolaei MR, Shapouri MSA. Seroprevalence and Risk factors of Akabane Virus Infection in cattle from Khouzestan Province of Iran. Iranian Journal of Virology. 2016. DOI: https://doi.org/10.21859/ISV.10.1.14

[26] Bangphoomi N, Takenaka-Uema A, Sugi T, Kato K, Akashi H, Horimoto T. Akabane Virus Utilizes Alternative Endocytic Pathways to Entry into Mammalian Cell Lines. Journal of Veterinary Medical Science. 2014. DOI: https://doi.org/10.1292/jvms.14-0155

[27] Toplu N, Oğuzoğlu TÇ, Akkoç A. Development of an In Situ Hybridization Method for Detection of Akabane Virus. Journal of Biological Methods. 2024. DOI: https://doi.org/10.14440/jbm.2024.413

[28] Chen D, Wang J, Wei F, Jing H, Wang D, Zhang Z, et al.. Characterization and double antibody sandwich ELISA application of a monoclonal antibody against Akabane virus nucleocapsid protein.. Journal of AOAC International. 2023. DOI: https://doi.org/10.1093/jaoacint/qsad025

[29] Wang J, Chen D, Wei F, Deng J, Su J, Lin X, et al.. Generation of Stable Cell Lines Expressing Akabane Virus N Protein and Insight into Its Function in Viral Replication. Pathogens. 2023. DOI: https://doi.org/10.3390/pathogens12081058

[30] Haligur M, Hasırcıoglu S, Ozmen O, Kale M, Aydoğan A. Immunohistochemical evaluation of akabane virus infection in aborted and new-born calves. Veterinarni Medicina. 2018. DOI: https://doi.org/10.17221/7516-VETMED

[31] Qiao J, Wang J, Meng Q, Wang G, Liu Y, He Z, et al.. Rapid detection of Akabane virus by a novel reverse transcription loop-mediated isothermal amplification assay (RT-LAMP). Virology Journal. 2013. DOI: https://doi.org/10.1186/1743-422X-10-288

[32] Na E, Chae S, Oh B, Jeong C, Park S, Oem J. A novel approach using IFNAR1 KO mice for assessing Akabane virus pathogenicity and vaccine efficacy.. Vaccine. 2025. DOI: https://doi.org/10.1016/j.vaccine.2025.127094

[33] Wang P, Zhang M, Qi Y, Cao X, Ji W, Li X, et al.. Genetic evolution of Akabane virus isolates and the protective efficacy of inactivated vaccines. Virology Journal. 2025. DOI: https://doi.org/10.1186/s12985-025-02998-y

[34] Li P, Zhang D, Deng M, Zhao D, Zhang Y, Cai S, et al.. Protoporphyrin IX targets viral spike glycoproteins to inactivate Akabane virus. Virulence. 2025. DOI: https://doi.org/10.1080/21505594.2025.2590264

[35] Golchin D, Sasani F, Moosakhani F, Badiei A, Zafari M, Nasr MP. Congenital cerebral and cerebellar anomalies in relation to bovine viral diarrhoea virus and Akabane virus in newborn calves.. Acta Veterinaria Hungarica. 2023. DOI: https://doi.org/10.1556/004.2023.00764

[36] Li X, Jing H, Liu X, Wang Q, Qiu S, Liu D, et al.. Comparative evaluation of two commercial ELISA kits for detection of antibodies against Akabane virus in cattle serum. BMC Veterinary Research. 2019. DOI: https://doi.org/10.1186/s12917-019-2156-6

[37] Lee H, Jeong H, Park S, Yang M, Kim J, Bae J, et al.. Experimental infection of cows with newly isolated Akabane virus strain (AKAV-7) causing encephalomyelitis. Veterinary Research. 2016. DOI: https://doi.org/10.1186/s13567-016-0349-6